Search clinical trials for: Rosiglitazone

Total 230 results

Malmö University
Skane University Hospital

Recruiting

Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.

Oral Lichen Planus

Sweden
Dan Zandberg

Recruiting

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

Melanoma | Hepatocellular Carcinoma | NSCLC | Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Urothelial Cancer | HNSCC | Microsatellite Instability-High Solid Malignant Tumor

United States
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight (SURMOUNT-2)

Obesity | Overweight | Type 2 Diabetes

United States, Russian Federation, Taiwan, Argentina, Brazil, Japan, Puerto Rico, India
Centro de Investigação em Saúde de Manhiça
University Health Network, Toronto; Barcelona Institute for Global Health

Completed

Rosiglitazone Adjunctive Therapy for Severe Malaria in Children (ROSI)

Malaria

Mozambique
Novo Nordisk A/S

Completed

Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide (REPAMET 2)

Diabetes Mellitus, Type 2 | Diabetes

Belgium
Ohio State University
GlaxoSmithKline; National Center for Complementary and Integrative Health (NCCIH) and other collaborators

Completed

Dietary Fatty Acids as Complementary Therapy in Type 2 Diabetes Mellitus (FACT)

Type 2 Diabetes Mellitus

United States
Biogen

Completed

BIIB014 Effects on the Pharmacokinetics (PK) of Rosiglitazone, Warfarin, and Midazolam

Healthy

United Kingdom
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Rosiglitazone in Treating Patients With Liposarcoma

Sarcoma

United States
GlaxoSmithKline

Completed

A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study

Diabetes Mellitus, Type 2

Japan
GlaxoSmithKline

Completed

BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-

Diabetes Mellitus, Type 2

Japan
Brigham and Women's Hospital
Patient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...

Active, not recruiting

Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study (CER-4-T2D)

Type2 Diabetes | Renal Disease | Cardiovascular Events

United States
Jean-Patrice Baillargeon
Canadian Institutes of Health Research (CIHR)

Completed

Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Canada
National Institute of Diabetes and Digestive and...

Completed

Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) (TODAY)

Diabetes Mellitus, Type II

United States
Assiut University

Completed

Injection of Dorsal Scapular n at Different Levels, Dose it Make Difference?

Pain, Chronic

Egypt
GlaxoSmithKline

Completed

Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease

Alzheimer's Disease

United States, Canada, United Kingdom
University of Sao Paulo
Escola Bahiana de Medicina e Saude Publica

Completed

Contraception in Women With Sickle Cell Disease

Sickle Cell Disease

Brazil
Gilead Sciences

Completed

Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection

Hepatitis C Virus Infection

United States, Belgium, Italy, United Kingdom
Jonsson Comprehensive Cancer Center
National Institutes of Health (NIH)

Terminated

Rosiglitazone in Treating Patients With Pituitary Tumors

Brain and Central Nervous System Tumors

United States
Jonsson Comprehensive Cancer Center
National Institutes of Health (NIH)

Terminated

Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)

Cushing's Disease

United States
PROCEPT BioRobotics

Completed

Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia III (AHAIII)

Benign Prostatic Hyperplasia

India
J JESUS VENEGAS, MD
Instituto Mexicano del Seguro Social; National Council of Science and Technology...

Completed

Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.

Insulin Resistance
Imperial College London
GlaxoSmithKline

Withdrawn

Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study

Diabetes Mellitus, Type 2

United Kingdom
Bayer

Completed

BAY73-4506 Probe Substrate Study

Neoplasms

Canada
Axio Biosolutions Pvt. Ltd.

Completed

Evaluating the Effectiveness of Axiostat Hemostatic Dressing Material Versus Conventional Method of Hemostasis and Healing of Extraction Wounds in Patients on Oral Anti-Platelet Drugs - A Comparative Study

Tooth Extraction
University Hospital, Montpellier

Completed

Effect of Rosiglitazone

Healthy

France
Novo Nordisk A/S

Terminated

Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

United States
Washington University School of Medicine

Completed

Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM (T2DM)

Diabetes Mellitus, Type II

United States
GlaxoSmithKline

Completed

Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health

Diabetes Mellitus, Type 2

United States, Argentina, Canada, Mexico, Spain, Estonia, Pakistan, Philippines
University of Washington
GlaxoSmithKline; Seattle Institute for Biomedical and Clinical Research

Completed

Preferred Treatment of Type 1.5 Diabetes

Type 2 Diabetes Mellitus

United States
GlaxoSmithKline

Completed

A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics

Diabetes Mellitus, Type 2

United States, Canada, Korea, Republic of, Australia, New Zealand
GlaxoSmithKline

Completed

AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Canada
GlaxoSmithKline

Completed

Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects

Diabetes Mellitus, Type 2

United States, Canada, Korea, Republic of, Australia, New Zealand, Mexico, Brazil
Charite University, Berlin, Germany

Completed

11ß-HSD1 and Metabolic Syndrome

Metabolic Syndrome | Impaired Glucose Tolerance

Germany
James Lewis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); G...

Completed

A Trial of Rosiglitazone for Ulcerative Colitis

Ulcerative Colitis | Inflammatory Bowel Disease

United States
GlaxoSmithKline

Completed

Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation

Drug Interactions

Korea, Republic of
GlaxoSmithKline

Completed

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

Diabetes Mellitus, Type 2

United States, Germany, Canada, Belgium, Denmark, Spain, Ireland, Netherlands, United Kingdom, Hungary, Italy, France, Austria, Czechia, Norway, Finland, Sweden
GlaxoSmithKline

Completed

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease (REFLECT-2)

Alzheimer's Disease

United States, Germany, France, Poland, Portugal, Spain, Canada, Argentina, Chile, India, Greece, Hungary, Italy, Japan, Austria, Brazil, Czechia, Mexico, Switzerland
Silva Arslanian
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study

Polycystic Ovary Syndrome

United States
GlaxoSmithKline

Terminated

Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers

Alzheimer's Disease

Australia, Spain, United States, Bulgaria, Germany, Belgium, Canada, Hong Kong, Korea, Republic of, Portugal, Argentina, Chile, Greece, Slovenia, Czechia, France, Hungary, Italy, South Africa, India, Sweden, Netherlands, Philippines, ... and more
GlaxoSmithKline

Terminated

Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers

Alzheimer's Disease

United States, Bulgaria, Germany, Estonia, Korea, Republic of, China, Greece, Hungary, Russian Federation, Philippines, Austria, Chile, Mexico, Croatia, New Zealand, Peru, Puerto Rico, United Kingdom
Zhaoyun Zhang

Unknown

A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas

Pituitary Tumor

China
GlaxoSmithKline

Completed

Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of Metformin

Diabetes Mellitus, Type 2
GlaxoSmithKline

Completed

AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone

Diabetes Mellitus, Type 2
GlaxoSmithKline

Completed

Efficacy and Safety In Poorly Controlled Type 2 Diabetics

Diabetes Mellitus, Type 2
Sun Yat-sen University

Suspended

Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes Mellitus
GlaxoSmithKline

Completed

The Effect Of AVANDIA On The Late Asthmatic Response

Asthma

New Zealand
GlaxoSmithKline

Completed

Effect of GSK376501 on CYP450 Activity in Healthy Adult Subjects

Diabetes Mellitus, Type 2

United States
GlaxoSmithKline

Completed

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease (REFLECT-3)

Alzheimer's Disease

United States, Australia, Spain, Bulgaria, Poland, Germany, Philippines, Singapore, Belgium, Canada, Hong Kong, Korea, Republic of, Finland, Slovenia, Czechia, France, South Africa, Sweden, Netherlands, Malaysia, United Kingdom, S...
GlaxoSmithKline

Completed

A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites.

Alzheimer's Disease

Germany
GlaxoSmithKline

Completed

Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate

Diabetes Mellitus, Type 2

United States

Search clinical trials for: Rosiglitazone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations